These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 11855679)

  • 81. The ocular penetration of levofloxacin 1.5% and gatifloxacin 0.3% ophthalmic solutions in subjects undergoing corneal transplant surgery.
    Holland EJ; McCarthy M; Holland S
    Curr Med Res Opin; 2007 Dec; 23(12):2955-60. PubMed ID: 17939882
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Pharmacodynamics of moxifloxacin and levofloxacin against Streptococcus pneumoniae, Staphylococcus aureus, Klebsiella pneumoniae and Escherichia coli: simulation of human plasma concentrations after intravenous dosage in an in vitro kinetic model.
    Odenholt I; Cars O
    J Antimicrob Chemother; 2006 Nov; 58(5):960-5. PubMed ID: 16936293
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Comparison of corneal and aqueous humor penetration of moxifloxacin, gatifloxacin and levofloxacin during keratoplasty.
    Fukuda M; Yamada M; Kinoshita S; Inatomi T; Ohashi Y; Uno T; Shimazaki J; Satake Y; Maeda N; Hori Y; Nishida K; Kubota A; Nakazawa T; Shimomura Y
    Adv Ther; 2012 Apr; 29(4):339-49. PubMed ID: 22529026
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Transfer of ciprofloxacin, ofloxacin and levofloxacin across the perfused human placenta in vitro.
    Polachek H; Holcberg G; Sapir G; Tsadkin-Tamir M; Polachek J; Katz M; Ben-Zvi Z
    Eur J Obstet Gynecol Reprod Biol; 2005 Sep; 122(1):61-5. PubMed ID: 16154040
    [TBL] [Abstract][Full Text] [Related]  

  • 85. In vivo measurement of levofloxacin penetration into lung tissue after cardiac surgery.
    Hutschala D; Skhirtladze K; Zuckermann A; Wisser W; Jaksch P; Mayer-Helm BX; Burgmann H; Wolner E; Müller M; Tschernko EM
    Antimicrob Agents Chemother; 2005 Dec; 49(12):5107-11. PubMed ID: 16304179
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Comparative pharmacokinetic disposition of fluoroquinolones in the lung.
    Wise R; Baldwin DR; Andrews JM; Honeybourne D
    J Antimicrob Chemother; 1991 Dec; 28 Suppl C():65-71. PubMed ID: 1664831
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Open-label crossover study to determine pharmacokinetics and penetration of two dose regimens of levofloxacin into inflammatory fluid.
    Child J; Mortiboy D; Andrews JM; Chow AT; Wise R
    Antimicrob Agents Chemother; 1995 Dec; 39(12):2749-51. PubMed ID: 8593013
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Tissue and serum concentrations of levofloxacin in orthopaedic patients.
    von Baum H; Böttcher S; Abel R; Gerner HJ; Sonntag HG
    Int J Antimicrob Agents; 2001 Oct; 18(4):335-40. PubMed ID: 11691565
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Lack of bioequivalence of levofloxacin when coadministered with a mineral-fortified breakfast of juice and cereal.
    Amsden GW; Whitaker AM; Johnson PW
    J Clin Pharmacol; 2003 Sep; 43(9):990-5. PubMed ID: 12971031
    [TBL] [Abstract][Full Text] [Related]  

  • 90. A population pharmacokinetic analysis of the penetration of the prostate by levofloxacin.
    Drusano GL; Preston SL; Van Guilder M; North D; Gombert M; Oefelein M; Boccumini L; Weisinger B; Corrado M; Kahn J
    Antimicrob Agents Chemother; 2000 Aug; 44(8):2046-51. PubMed ID: 10898674
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Lung microdialysis study of levofloxacin in rats following intravenous infusion at steady state.
    Marchand S; Frasca D; Dahyot-Fizelier C; Breheret C; Mimoz O; Couet W
    Antimicrob Agents Chemother; 2008 Sep; 52(9):3074-7. PubMed ID: 18591278
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Mechanistic study of inhibition of levofloxacin absorption by aluminum hydroxide.
    Tanaka M; Kurata T; Fujisawa C; Ohshima Y; Aoki H; Okazaki O; Hakusui H
    Antimicrob Agents Chemother; 1993 Oct; 37(10):2173-8. PubMed ID: 8257141
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Pharmacokinetics of intravenous levofloxacin administered at 750 milligrams in obese adults.
    Cook AM; Martin C; Adams VR; Morehead RS
    Antimicrob Agents Chemother; 2011 Jul; 55(7):3240-3. PubMed ID: 21576432
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Delivering antibacterials to the lungs: considerations for optimizing outcomes.
    Cazzola M; Blasi F; Terzano C; Matera MG; Marsico SA
    Am J Respir Med; 2002; 1(4):261-72. PubMed ID: 14720046
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Addition of a 2-month low-dose course of levofloxacin to long-term erythromycin therapy in sinobronchial syndrome.
    Fujimura M; Mizuguchi M; Nakatsumi Y; Mizuhashi K; Sasaki S; Yasui M;
    Respirology; 2002 Dec; 7(4):317-24. PubMed ID: 12421239
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Urothelial mucosal concentration of levofloxacin administered before transurethral resection: Is the mucosal concentration predictable?
    Hattori T; Kimura G; Kondo Y; Horiuchi K; Tsuboi N; Yoshida K; Akimoto M
    Int J Urol; 2001 Apr; 8(4):171-6. PubMed ID: 11260349
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Entry of the new quinolone antibacterial agents of ofloxacin and NY-198 into the central nervous system in rats.
    Sato H; Okezaki E; Yamamoto S; Nagata O; Kato H; Tsuji A
    J Pharmacobiodyn; 1988 Jun; 11(6):386-94. PubMed ID: 3171880
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Effect of aluminium ion on bioavailability of levofloxacin following oral administration of cilexetil ester of levofloxacin as prodrug in rats.
    Shinmachi K; Takahashi Y; Kaneuji Y; Kawamura R; Kohama K; Hieda Y; Goromaru T; Eto S; Murakami T; Maeda Y
    Pharmazie; 2020 Nov; 75(11):554-558. PubMed ID: 33239128
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Modeling of transfer kinetics at the serum-cerebrospinal fluid barrier in rabbits with experimental meningitis: application to grepafloxacin.
    Pfister M; Zhang L; Hammarlund-Udenaes M; Sheiner LB; Gerber CM; Täuber MG; Cottagnoud P
    Antimicrob Agents Chemother; 2003 Jan; 47(1):138-43. PubMed ID: 12499181
    [TBL] [Abstract][Full Text] [Related]  

  • 100. A Novel Drug-Drug Cocrystal of Levofloxacin and Metacetamol: Reduced Hygroscopicity and Improved Photostability of Levofloxacin.
    Shinozaki T; Ono M; Higashi K; Moribe K
    J Pharm Sci; 2019 Jul; 108(7):2383-2390. PubMed ID: 30807761
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.